A Small Molecule, Orally Active, Α4β1/Α4β7 Dual Antagonist Reduces Leukocyte Infiltration and Airway Hyper-Responsiveness in an Experimental Model of Allergic Asthma in Brown Norway Rats

British Journal of Pharmacology - United States
doi 10.1038/sj.bjp.0706658